Immunoglobulins - Basic considerations (Journal of Neurology (2006) 253, (SUPPL. 5) (9-47) DOI: 10.1007/s00415-006-5002-2);Immunoglobulins - Basic considerations

Journal of Neurology

Volumn 253, Issue SUPPL. 5, 2006, Pages 308-

  Mix, Eilhard ^a   Goertsches, Robert ^a   Zett, Uwe K ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Antibody diagnostics; Antibody genetics; Antibody structure; Antibody therapy; B cells; Monoclonal antibodies

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ALLERGY; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; COMPLEMENT FIXATION; CONFERENCE PAPER; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMOLYTIC ANEMIA; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOADSORPTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN STRUCTURE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOPRECIPITATION; INFECTION; INNATE IMMUNITY; INTOXICATION; LEUKEMIA; LYMPHOMA; MEMBRANE TRANSPORT; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PLACENTAL TRANSFER; PRECIPITATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEROLOGY; SOLID TUMOR;

EID: 33748971878     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0881-z     Document Type: Erratum

References (15)

1. Chambers SA, Isenberg D (2005) Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus 14:210-214
2. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA (2006) The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy. J Neurol 253:98-108
3. Coombs, RRA, Gell PGH (1963) The classification of allergic reactions underlying disease. In: Gell PGH, Coombs RRA (eds) Clinical aspects of immunology. Davis, Philadelphia, pp 317 ff
4. Edelman GM (1959) Dissociation of γ-globulin. J Am Chem Soc 81:3155-3156
5. Glick B, Chang TS, Jaap RG (1956) The bursa of Fabricius and antibody production. Poultry Sci 35:224-225
6. Ishizaka K, Ishizaka T (1966) Physicochemical properties of reaginic antibody. III. Further studies on the reaginic antibody in gamma-A-globulin preparations. J Allergy 38:108-119
7. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol (Paris) 125C:373-389
8. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497
9. Mix E, Meyer-Rienecker H (1996) Fetal-type lymphocytes in blood and cerebrospinal fluid (CSF) in inflammatory diseases of the central nervous system (CNS). J Lab Med 20:166-167
10. nd edition. Walter de Gruyter, Berlin-New York, pp 95-125
11. Olsson T, Edenius C, Ferm M, Samuelson P, Torrang A, Wallstrom E, Khademi M, Andersson M, Arfors L (2002) Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis. Eur J Neurol 9:153-164
12. Porter RR (1959) The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem J 73:119-126
13. Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323-327
14. Stanworth DR, Humphrey JH, Bennich H, Johansson SG (1967) Specific inhibition of the Prausnitz-Küstner reaction by an atypical human myeloma protein. Lancet 2:330-332
15. Toyka KV, Brachmann DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397-399